Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 102kWORD 19k
30 April 2018
Answer given by President Juncker on behalf of the Commission
Question reference: E-000728/2018

Paragraph 15 of the Guidelines for Brexit negotiations of the European Council (Article 50) of 29 April 2017 states that ‘the future location of the seats of EU agencies and facilities located in the United Kingdom is a matter for the 27 Member States to settle rapidly’(1).

In the margins of the European Council (Article 50) of 22 June 2017, the Heads of State or Government of 27 Member States endorsed the Procedure leading up to a decision on the relocation of the European Medicines Agency and the European Banking Authority(2). The Commission was invited to examine the offers submitted by the Member States and to present its assessment to the Secretary-General of the Council.

For this purpose, the Commission was provided by the Secretary-General of the Council with both the public and the confidential versions of Member States’ offers. In its assessment, therefore, the Commission considered the totality of the information submitted by the Member States(3).

The offer from the Netherlands for the European Medicines Agency can be found on the website of the Council, including the part of the offer which had initially been confidential but in the meantime was made publicly available(4).

In accordance with the endorsed procedure, on 20 November 2017 the 27 Member States selected Amsterdam as the new seat for the European Medicines Agency. Detailed practical information on the voting method was published on the website of the Council on 9 November 2017. The Commission did not take part in this vote, nor did it have any other formal role in the decision-making process regarding the new locations for the two Agencies.

(3)The Commission’s methodology for assessing the Member States' offers to host one or both of the London-based EU agencies is further set out in its Note of September 2017: https://ec.europa.eu/info/sites/info/files/commission-assessment-cover-note.pdf

Last updated: 3 May 2018Legal notice